The former begins with Adenomatous Polyposis Coli (APC) mutation, followed by Rat Sarcoma virus (RAS) protein activation or Tumor-Protein p53 (TP53) loss of function, and accounts for 70–90% of CRC cases. The gene discussed is TP53; the disease is colorectal carcinoma.